Skip to content

Clinical trials

Lymphoproliferative Disorders trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Country / region: Spain Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20113
20121
20141
20151
20174
20181
20192
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated6
Active, not recruiting3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen Research (Munich) GmbH2
Pierre Fabre Medicament2
Acerta Pharma BV1
Amgen1
Ariad Pharmaceuticals1
Celgene1
Cellectar Biosciences, Inc.1
Curis, Inc.1
European Association of Urology Research Foundation1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders18
Lymphatic Diseases11
Immunoproliferative Disorders10
Lymphoma10
Lymphoma, Non-Hodgkin9
Neoplasms9
Immune System Diseases8
Lymphoma, Large B-Cell, Diffuse6
Hematologic Diseases4
Leukemia4

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.